Business
Some executives anticipate an acceleration of M&A activity as struggling startups seek exits, while others foresee more funding opportunities for companies with proven value in the sector.
The acquisition bolsters CCC's AI-powered SaaS platform by adding transformative AI capabilities.
Leaders weigh in on the digital health funding environment, women's health investments and how "AI washing" may influence capital raises.
The company touts that it recently surpassed 2.5 million rings sold and has seen its member base and revenue more than double over the past year.
The Series A investment brings the company's total capital raise to $20 million.
The company will use the funds to drive adoption of its platform and provide capital infusion for expansion in the health markets.
The company will use the funds to increase the development of its computational platform to predict patient treatment responses and support drug research & development.
The funding brings the company's Series C funding round to a close and total capital raised to $155 million.
The company will use the funds to accelerate the development of its Ellipse Spinal Cord Stimulator Platform, used to treat chronic pain.
AI and automation revenue cycle management tools will be accessible to 160,000 physicians.